Similar Search Results - EconBiz

Cost savings associated with filling a 3-month supply of prescription medicines

Rabbani, Atonu; Alexander, G. - In: Applied Health Economics and Health Policy 7 (2009) 4, pp. 255-264

Although such opportunities are not universally available, these findings quantify the cost savings that patients in the US can achieve through filling larger quantities of a prescription for a chronic condition. </AbstractSection> Copyright Adis Data Information BV 2009

Persistent link: https://www.econbiz.de/10011000740

Rushed innovation : evidence from drug licensing

Hermosilla, Manuel - In: Management science : journal of the Institute for … 67 (2021) 1, pp. 257-278

Persistent link: https://www.econbiz.de/10012435267

Regulating ethical experimentation : impacts of the breakthrough therapy designation on drug R&D

Hermosilla, Manuel - In: Journal of health economics 94 (2024), pp. 1-26

Persistent link: https://www.econbiz.de/10014549760

Pharmaceutical profits and the social value of innovation

Dranove, David; Garthwaite, Craig; Hermosilla, Manuel - 2014

Persistent link: https://www.econbiz.de/10010380923

Prospective adverse event risk evaluation in clinical trials

Kundu, Abhishake; Feijoo, Felipe; Martinez, Diego A.; … - In: Health care management science : a new journal serving … 25 (2022) 1, pp. 89-99

Persistent link: https://www.econbiz.de/10013184877

Can emerging markets tilt global product design? : impacts of Chinese colorism on Hollywood castings

Hermosilla, Manuel; Gutiérrez-Navratil, Fernanda; … - In: Marketing science : the marketing journal of the … 37 (2018) 3, pp. 356-381

Persistent link: https://www.econbiz.de/10011884340

Structural models of the prescription drug market

Ching, Andrew; Hermosilla, Manuel; Liu, Qiang - 2019

Persistent link: https://www.econbiz.de/10012157474

Market size and innovation : the intermediary role of technology licensing

Hermosilla, Manuel; Wu, Yufei - In: Research policy : policy, management and economic … 47 (2018) 5, pp. 980-991

Persistent link: https://www.econbiz.de/10011973872

Does bad medical news reduce preferences for generic drugs?

Hermosilla, Manuel; Ching, Andrew - In: Journal of marketing 88 (2024) 1, pp. 160-178

Persistent link: https://www.econbiz.de/10014582843

Does consumer demand pull scientifically novel drug innovation?

Dranove, David; Garthwaite, Craig; Hermosilla, Manuel - In: The Rand journal of economics 53 (2022) 3, pp. 590-638

Persistent link: https://www.econbiz.de/10013464979

A service of the